Opus Genetics, Inc. (IRD)

SEC filing

Opus Genetics, Inc.

IRD · CIK 1228627

4 · Sep 8, 2026 · Chief Financial Officer Gagnon Robert E. sold 28K shares at $4.54/share ($127.2K)

Chief Financial Officer Gagnon Robert E. sold 28K shares at $4.54/share ($127.2K)

Could not load the primary document from EDGAR (SEC rate limit, timeout, or temporary upstream error). Refresh in a minute, or use View on SEC.gov.